Introduction In a case controlled analysis, we attempted to determine if the volume-survival benefit persists in liver resection (LR) after eliminating differences in background characteristics. Methods Using the Nationwide Inpatient Sample (NIS), we identified all LR (n=2,949) with available surgeon/hospital identifiers performed from 1998-2005. Propensity scoring adjusted for background characteristics. Volume cut-points were selected to create equal groups. A logistic regression for mortality was then performed with these matched groups. Results At high volume (HV) hospitals, patients (n=1423) were more often older, white, private insurance holders, elective admissions, carriers of a malignant diagnosis, and high income residents (p<0.05). Propensity matching eliminated differences in background characteristics. Adjusted in-hospital mortality was significantly lower in the HV group (2.6% vs. 4.8%, p=0.02). Logistic regression found that private insurance and elective admission type decreased mortality; preoperative comorbidity increased mortality. Only LR performed by HV surgeons at HV centers was independently associated with improved in-hospital mortality (HR, 0.43; 95% CI, 0.22-0.83). Conclusions A socioeconomic bias may exist at HV centers. When these factors are accounted for and adjusted, center volume does not appear to influence in-hospital mortality unless LR is performed by HV surgeons at HV centers.
Introduction
In advanced surgical procedures, improved outcomes may be directly related to volume for both hospitals and surgeons. [1] [2] [3] [4] High volume (HV) surgeons and centers have improved outcomes with complex surgical procedures including major cancer surgery in population-based studies. 1, 2, 5 Examples of a volume based effect include carotid endarterectomy (CEA), coronary artery bypass grafting, aortic valve replacement, elective repair of abdominal aortic aneurysm (AAA), resection for lung cancer, esophagectomy, and pancreatic resection. 2, 6, 7 What is the relationship and significance of surgeon and center volume? In vascular surgery, HV surgeons have improved outcomes regardless of the volume of the hospital after CEA and AAA repair.
due to patient factors. Patient race, socioeconomic status, and geography are associated with an increased incidence of cardiovascular disease and increased mortality. 8, 9 Furthermore, patients with low income, low level of education, or multiple comorbidities have worse outcomes in terms of cancer survival. 10 Patient payer status has also been associated with poor outcome, as uninsured patients have higher operative mortality for both elective and emergent AAA repair. 11 Liu et al. showed that in California, blacks and Hispanics are much less likely to be treated at a HV facility for complex surgery. 12 The assumption for better patient outcomes by HV surgeons is that their surgical expertise is derived from repetition. However, it is possible that the mortality benefit of HV surgeons may be due in part to favorable patient characteristics. Few studies have examined the effect of surgeon volume on outcome while controlling for confounding factors within the patient population including race/ethnicity, socioeconomic status, insurance type, and comorbidity. We attempted to determine if improved outcomes by HV surgeons, specifically in the case of liver resection (LR), are reproducible when patient demographic factors are controlled at the population level.
Material and Methods
A retrospective analysis was performed using discharge records from the Nationwide Inpatient Sample (NIS) from 1998-2005 for all patients who underwent LR for which surgeon and hospital identifiers were available. The NIS is the largest US all-payer database for inpatient medical records. The Healthcare Cost and Utilization Project supports the database, which contains all patient discharge records from participating hospitals. The sample constitutes about 20% of hospital discharges in the United States. Seven million hospital discharges per year are compiled from one fifth of nonfederal community hospitals including both academic and specialty hospitals.
This study was reviewed by and received exemption from the University of Massachusetts Institutional Review Board as no personal identifiers are listed in the NIS data.
Study Population
The Clinical Modification of the International Classification of Diseases, 9th Revision (ICD-9-CM) diagnostic and procedural codes was used to identify diagnoses and procedures. Liver resection was defined as either a wedge resection or lobectomy (hemihepatectomy) for any cause. Patients who underwent LR (primary procedure code 50.22 or 50.3) were identified and included only if hospital and surgeon identifier data were available. This comprised 2,952 of 9,989 total LR (29.6%) performed in the NIS over the 8-year period. We excluded liver transplantation, total hepatectomy or other nonresectional liver procedures. We also excluded all cases with admission types of "newborn" or "trauma."
To evaluate volume, we categorized groups based on approximately equal sizes for purposes of comparison prior to any volume-outcome data analysis, as previously described. 6, 13, 14 Provider Identifiers Hospital and surgeon identifiers were used to determine the number of LR per individual hospital and surgeon. Since record sampling in the NIS does not correlate across years, a continuous single surgeon identifier was not possible. Each record or identifier is considered a unit assigned to a specific surgeon or hospital; therefore, the same surgeon may operate in each year recorded as a different individual surgeon. For example, due to the sampling in the NIS, it is possible for a surgeon's hospital to be included in 1 year and then not included the following year. Due to the variable for surgeon identifier changing twice during the study period and to concerns regarding the fidelity of surgeon and/or hospital identifiers from year to year, all volume calculations were done on a year to year basis. Extrapolation of the dataset using institutional weighting was not performed. In order to create equal cutoff groups, HV hospitals were defined as ≥20 LR/year and HV surgeons performed ≥10 LR/year.
Variables
Patient demographic characteristics compiled in the NIS were used. Age was incorporated as a continuous variable. Race was categorized by the following groups: white, black, Hispanic, or other (Asians, Pacific Islanders, and Native Americans). Race was missing in 9.5% of cases in this cohort. Income bracket, a categorical variable, was created by using the corresponding median household income from the respective residential zip code. For the years 1998-2002, quartiles were created based on demographics from 1999 where the maximum of the first quartile equaled 150% of the poverty level and the second and third quartiles were divided using the national median income as the upper limit of the second quartile. For the years 2003-2005, annual adjustments were made to separate patients equally with the same division between the second and third quartile. Due to changes in the variable during the years of study, a separate variable was created for highest income bracket. Four payer status groups were created including: Medicare, Medicaid, private insurance, or other.
To evaluate comorbidity the Elixhauser comorbidity index was used. 15 This previously validated index identifies 29 specific disease entities that are considered true preoperative comorbidities rather than complications of care. 16 Scores between zero and three were created based on how many comorbid diseases patients had.
Outcomes
Mortality was the primary endpoint examined in this study and was defined as death due to any cause prior to discharge. Secondary endpoints included cost of hospitalization and discharge location.
Case-controlled Analysis
Propensity scores were used to further investigate whether differences in outcomes at HV and LV centers were dependent on differences in patient population and disease characteristics as previously described. (Csikesz et al. in press) Candidate factors for the propensity model included available demographic and disease factors. The propensity groups markedly reduced demographic and hospital differences between patients who were treated at different volume centers. 17, 18 A matched cohort was created in which all demographic/disease characteristic differences between HV and LV centers (n=767 in each group) were eliminated, allowing us to evaluate the effect of volume on mortality in a case-control fashion. Within each group, the association between each demographic or disease characteristic was determined by the χ 2 test. Univariate predictor variables with a p<0.10 were included in the multivariate analysis. The effect of LR on the probability of in-hospital mortality, while controlling for confounding variables was accomplished using a logistical regression. A Hosmer-Lemeshow goodness-of-fit test confirmed the model. Variables assessed by logistical regression included: age (continuous), sex, race (white, black, Hispanic, or other), primary insurance (Medicare, Medicaid, private, or other), admission type (elective or emergent/urgent), Elixhauser comorbidity score, malignant diagnosis, and volume status. A model was first developed and included the comparisons of LV and HV surgeons and hospitals separately. Income level was not included in the logistic regression due to changes in coding and tracking over the years in the study. Then, separate models were used to test the effect of different surgeon/hospital volume combinations. Models were run with and without patients with missing variables. In order to account for variability in wedge resections, a separate model was run for only hemihepatectomy to ensure the findings are broadly applicable over varying degrees of LR.
Adjusted regression and mortality assessments were then performed on the case-controlled groups. The outcome variable was again in-hospital mortality. P values<0.05 were considered statistically significant. Logistical regression data were tabulated as hazard ratios and 95% confidence interval (CI).
Results

Demographics
Over the 8-year period, 2,949 LRs were included in this cohort from the NIS. The median number of states involved in the study was seven per year (range 4-9). The median number of surgeons per year involved in the study was 134 surgeons (range 98-163). Surgeons performed a median of one LR per year (range 1-83). A median of 64 hospitals performed a LR in a given year in this cohort (range 49-79). The median hospital volume of LR was two per year (range (Fig. 1 ). Of these, 1,526 were performed at LV centers (60.1% wedge resections and 39.9% lobectomies) and 1,423 were performed at HV centers (50.9% wedge resections and 49.1% lobectomies). Low volume surgeons performed 1,767 LRs, 1,393 at LV hospitals and 374 at HV hospitals. High volume surgeons completed 1,182 LR, 133 at LV hospitals and 1,049 at HV hospitals (Fig. 2) . Table 1 demonstrates the demographics of the cohort. Patients treated at high volume centers were more likely to be older (57 years vs. 56 years), white race (76% vs. 69%), recipients of private insurance (56% vs. 48%), treated in an elective setting (93% vs. 79%), members of the highest income bracket (41% vs. 34%), and carriers of a malignant diagnosis (81% vs. 74%) (p<0.05). The median Elixhauser score was one and there was no difference in comorbidity between the two hospital groups.
Patient Outcomes
At HV centers patients were discharged home more frequently (78% vs. 75%), had higher mean total charges ($55,400 vs. $45,200), and a lower unadjusted mortality (3.2% vs. 6.5%)(p<0.05). A multivariable logistic regres-sion was completed and independent variables predictive of in-hospital mortality were calculated ( In combination, only treatment by a HV surgeon at a HV center was associated with a 50% reduction in the risk of mortality (HR, 0.53; 95% CI, 0.32-0.89 (Table 3) ). A separate analysis of only hemihepatectomy achieved similar results to ensure that this result is applicable over varying degrees of LR. Since LRs are commonly elective operations, a separate analysis omitting emergent LR was performed as well. There was no difference in results using only elective LRs in this cohort.
Adjusted Mortality Models
Distributions of measure variables were comparable between groups ensuring that presentation to high or low volume centers and surgeons was unrelated to patient traits. A total of 1,678 patients comprised this case-controlled cohort. Patients who underwent LR at HV hospitals had a lower adjusted mortality rate (2.6% vs. 4.8%; p=0.02) compared to LV hospitals. A logistical regression of propensity matched groups was then performed to determine if independent risk factors for in-hospital mortality existed in this case-controlled cohort ( 
Discussion
Specialized procedures require surgical expertise, modern and up-to-date tertiary services, and patients who can tolerate surgery safely. Using the surgeon and hospital identifier in the NIS, we have found that a complex interplay between surgeon, center, and patient factors determines outcome after LR. Many surgical procedures have better outcomes when performed by HV surgeons or centers, but the volume-outcome relationship is not welldefined. 19, 20 A volume-based outcome analysis is applicable to only a very small segment of surgical care and may apply only to a subgroup of operations. 21 Use of database research has elucidated some aspects of provider standards and outcomes after surgery. However, the reasons for In large population-based studies, improved unadjusted results may appear to be better at HV hospitals. 5, 13, 22 This is due to inherent assumptions about the large cohort that are commonly accepted. 23 We have shown in this cohort of LR from the NIS database that a socioeconomic bias may exist at HV hospitals. Specifically, HV hospitals treated patients who were more often white, had private insurance, and were located in high income residencies. After eliminating these differences to create a case-controlled analysis between LV and HV hospitals, an adjusted mortality benefit was still evident at HV hospitals. Although these factors are controlled for in the propensity scoring, they still bear out an increased risk for mortality. When independently examined, within each subgroup, mortality rates are higher in LV hospital than HV hospitals (4.8% vs. 2.6%) despite controlling for the frequency of these demographic variables. This further emphasizes their effect in outcomes after LR in this cohort.
Surgeon volume was not protective independent of hospital volume. In this study the majority of liver resections completed by HV surgeons (89%) were done at HV hospitals. Similarly, LV surgeons tended to operate at LV centers (79%). Since improved mortality was not demonstrated independent of center volume, favorable patient characteristics may have led to the mortality benefit of other studies. Could part of the mortality benefit enjoyed by HV surgeons in other studies be due to beneficial patient characteristics? Although demographics may appear similar, causal effects and background characteristics from large data sets can be controlled by propensity scores. This method of case-controlled analysis makes the results more assessable and transparent. 23 Others have hypothesized that the volume parameters to determine "high" and "low" volume are misleading. We used equal groups to determine our volume threshold; this method is accepted but may not be the most accurate predictor of a volume-outcome effect. 19, 24 Statistical analysis to determine a 'best-fit' for volume cutoffs using pseudo-r 2 resulted in unacceptably low cutoffs (data not shown). 24 There are many factors which may lead to improved outcomes at HV centers including both those inherent to the hospital such as specialization, dedicated care teams and units, and clinical pathways. We have previously shown that centers that support transplantation achieve better perioperative mortality after liver and pancreas surgery regardless of surgeon specialization or volume (Csikesz et al. in press). Other processes of care that have been shown to independently improve patient outcomes after surgery include surgical specialization, 1, 25 intensive care specialists running intensive care units, 26, 27 multidisciplinary care, 28 and surgeon experience. 29 Furthermore, the effect of the interplay between hospital and surgeon volume may impact outcomes as well. This is a growing area of research that may help identify better parameters of "quality" or create more accurate risk adjustment to assess outcomes after surgery.
Several limitations to this study must be considered. This was a retrospective study and has the associated constraints due to the level of the NIS data. For example, we were unable to confirm the validity and accuracy of the diagnostic and procedure coding. 30 The main outcome measure of this study was in-hospital mortality. This may reflect a lower mortality rate compared with studies using 30-day mortality as most patients were likely discharged from the hospital prior to the potential death (if applicable). Our study used population-based data with only limited information on patient and treatment factors, thereby Hazard Ratio Figure 3 Logistic regression plot of hazard ratios for in-hospital mortality of volume groups in the case-controlled analysis. Referent value is LV surgeon/LV hospital (HV high volume, LV low volume, Hosp hospital, Surg surgeon). In order to account for this, we calculated the mortality rates for the whole NIS cohort for LR and did not find any difference in mortality among states with surgeon/hospital identifiers and those without. We also did not identify any significant regional differences in our cohort and states had uniform distribution of demographic and patient characteristics.
In conclusion, this large cohort of patients who underwent LR suggests that a socioeconomic bias may exist at HV centers. When these factors are accounted for and adjusted, center volume does not appear to influence in-hospital mortality unless LR is performed by HV surgeons at HV centers. Further processes of care that contribute to improved outcomes continue to be defined as volume may only be a surrogate for these other factors that improve patient care.
Elijah Dixon, M.D. (Calgary, Alberta, CA): Dr. Shah, I would like to congratulate you on a nice presentation and a well written manuscript. You have taken a closer look at the volume outcome relationship as it applies to hepatic surgery and tried to drill down and see what effect the individual surgeon and hospital or institutional volume has on outcomes. The analysis that you used is a combination of standard logistic regression analysis and a case control matched analysis with propensity scores. You found that there were differences in the socioeconomic means of the patients that are treated at high and low volume hospitals, and that the individual effects of both surgeon and hospital volume on outcome are fairly weak, and that only the two of them together show us a statistically significant effect on postoperative mortality. So, I have three quick questions for you.
The first is, can you comment on how significantly you think your results or the lack of volume outcome effect can be explained by differences in case complexity at high and low volume centers and our inability to measure the differences in case complexity using administrative data? The second question. There is some evidence that volume may in fact be a surrogate for other aspects of care, and I wonder if you could hypothesize what some of the structural and process of care issues may be that can explain some of the volume outcome effect. And third, your analysis used two techniques. The case control matched analysis used a much smaller data set, a subset of your data, and I wonder if you could comment on what the value of that analysis is and its relative strength in comparison to the standard multivariate regression.
Thank you. I enjoyed your presentation.
To answer your first question, the case complexity is something that we are not going to be able to account for in most administrative databases. Some of the cancer databases might allow us to look at tumor size, but even then, it is not going to give us the accurate assessment of how much work a high volume or low volume surgeon would have to do in a liver resection. And probably in that regard, as some centers have done already, we are going to need to collate some of our data and look at it prospectively and combine centers' experiences and try to understand this phenomenon. Maybe the high volume surgeons are doing more complex cases, so therefore the mortality benefit that you get is underscored in a study like this. In terms of processes of care, I think with liver resection it is especially unique and isn't really accounted for in large population-based studies. For instance, high volume centers probably have a multidisciplinary tumor conference; if you work at a transplant center, that might account for improved outcomes after liver resection; whether you are at teaching hospital or a nonteaching hospital; or even something like having two high volume surgeons in a single center that work together during a liver resection probably improves outcomes. These kinds of factors are not accounted for in a large database. Our group has previously shown that liver resection at a transplant center significantly improves outcomes in terms of in-hospital mortality.
The use of propensity scores allows us to do a case controlled analysis. When you perform a logistic regression of thousands of patients, you are assuming that the cohorts are similar when they are not. So although you might find significant factors that are "independent", we really don't believe that they are truly independent unless you trim down the cohorts and make sure that the demographic and the hospital factors are similar.
Myrddin Rees, M.D. (Baskingstoke, UK): I have been a low volume surgeon in a low volume hospital, and I am currently a high volume surgeon in a high volume hospital, doing over 200 resections of the liver a year. I am also president of your sister organization, the Association of Upper Gastrointestinal Surgeons for Great Britain and Ireland. I would like to give you a U.K. perspective, which I think is relevant to this paper, which I enjoyed very much.
Over the past five years, two important things have occurred in England. We have centralized all major cancer resections for the esophagus, pancreas, and the liver. So we now only have high volume centers. However, we still had a spate of young surgeons being suspended in their first year as a consultant. As a result, AUGIS decreed and advised that all young surgeons be mentored for up to five years. So at my center we have three surgeons, and though I do the majority, my youngest surgeon always has me as first assistant on any difficult operation. As a consequence our results are the same and equal, and I recommend to you the team approach.
Thank you.
Nicholas J. Zyromski, M.D. (Indianapolis, IN): Congratulations on a beautiful presentation of a provocative paper. I understand that your outcome measure on this was specifically in-hospital mortality. My question is, does this database allow you to look at long-term survival and is that something that you are thinking about looking at in this situation?
Shimul A. Shah, M.D. (Worcester, MA): Unfortunately, this database doesn't allow us to look at long-term survival. So one thing that we are going to look into next is some of the cancer databases. Unfortunately, they don't always track surgeon volume, which is one of the limitations why it probably hasn't been done before. I think the key is getting a lot of people in this audience together and seeing what our own data is. Unfortunately, probably most of the people in this room are high volume surgeons, and in order to do some of these studies well, I think we need to get the low volume surgeons involved as well. Thank you.
